American Portfolios Advisors Vertex Pharmaceuticals Inc Transaction History

American Portfolios Advisors

  • $2.36 Trillion
  • Q3 2022

A detailed history of American Portfolios Advisors transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, American Portfolios Advisors holds 665 shares of VRTX stock, worth $299,895. This represents 0.01% of its overall portfolio holdings.

Number of Shares
665
Holding current value
$299,895
% of portfolio
0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Mar 17, 2023
BUY
$273.83 - $305.53 $182,096 - $203,177
665 New
665 $193 Million
Q2 2022

Mar 20, 2023
BUY
$234.96 - $292.55 $26,785 - $33,350
114 Added 17.14%
779 $220 Million
Q1 2022

Mar 21, 2023
BUY
$221.42 - $260.97 $59,561 - $70,200
269 Added 40.45%
934 $244 Million
Q4 2021

Mar 21, 2023
BUY
$177.01 - $223.45 $87,442 - $110,384
494 Added 74.29%
1,159 $255 Million
Q3 2021

Mar 22, 2023
BUY
$181.39 - $202.99 $103,573 - $115,907
571 Added 85.86%
1,236 $224 Million
Q2 2021

Mar 22, 2023
BUY
$187.49 - $221.1 $510,535 - $602,055
2,723 Added 409.47%
3,388 $683 Million
Q1 2021

Mar 22, 2023
BUY
$207.02 - $241.31 $543,634 - $633,680
2,626 Added 394.89%
3,291 $707 Million
Q4 2020

Mar 22, 2023
BUY
$207.01 - $276.09 $513,384 - $684,703
2,480 Added 372.93%
3,145 $743 Million
Q3 2020

Mar 22, 2023
BUY
$255.65 - $303.1 $599,754 - $711,072
2,346 Added 352.78%
3,011 $819 Million
Q2 2020

Mar 24, 2023
BUY
$225.48 - $295.8 $521,084 - $683,593
2,311 Added 55.31%
6,489 $1.88 Billion
Q1 2020

Mar 24, 2023
BUY
$199.77 - $247.81 $701,792 - $870,556
3,513 Added 528.27%
4,178 $994 Million
Q4 2019

Mar 24, 2023
BUY
$166.71 - $223.91 $454,284 - $610,154
2,725 Added 409.77%
3,390 $742 Million
Q3 2019

Mar 24, 2023
BUY
$166.23 - $187.09 $26,264 - $29,560
158 Added 5.3%
3,139 $532 Million
Q2 2019

Mar 24, 2023
BUY
$164.61 - $190.37 $381,236 - $440,896
2,316 Added 348.27%
2,981 $547 Million
Q1 2019

Mar 24, 2023
BUY
$163.73 - $194.7 $35,365 - $42,055
216 Added 57.75%
590 $109 Million
Q4 2018

Mar 24, 2023
BUY
$151.91 - $192.21 $10,026 - $12,685
66 Added 21.43%
374 $62 Million
Q3 2018

Mar 24, 2023
SELL
$167.73 - $192.74 $59,879 - $68,808
-357 Reduced 53.68%
308 $59.4 Million
Q2 2018

Mar 24, 2023
BUY
$145.72 - $169.96 $21,275 - $24,814
146 Added 90.68%
307 $52.2 Million
Q1 2018

Mar 24, 2023
SELL
$151.6 - $177.13 $76,406 - $89,273
-504 Reduced 75.79%
161 $26.2 Million

Others Institutions Holding VRTX

# of Institutions
1,723
Shares Held
222M
Call Options Held
1.58M
Put Options Held
1.36M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $116B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track American Portfolios Advisors Portfolio

Follow American Portfolios Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

News

Stay updated on American Portfolios Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email